PATENT CLAIM ANALYSIS

Application Number: 15956232
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "574000"]

Abstract:
Methods for the treatment of homozygous familial hypercholesterolemia, compound heterozygous familial hypercholesterolemia, or heterozygous familial hypercholesterolemia by administering gemcabene as an adjunct to other lipid lowering therapy and/or modified diet.

Claim (Index 50):
The method of  claim 49 , wherein the compound is 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethyl-hexanoic acid and is administered as the monocalcium salt of 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethyl-hexanoic acid.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 91.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14801384', '14539199', '13982373', '13982381', '14370722']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7826404478140823
- 35 USC 102 Novelty (BERT): 0.546321580898825
- Combined Prediction Score: 0.7590085611225565
- Mean Citation Score: 376.79971600000016
- Max Citation Score: 447.5305
- Similarity Product: 234.37993820595744

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test